According to a new report published by OG Analysis, the global Companion Diagnostics Oncology Market is valued at USD 5.11 billion in 2026 and is projected to reach USD 12.31 billion by 2034, expanding at a CAGR of 11.61%. Growth is being driven by the rapid expansion of targeted cancer therapies, immuno-oncology, biomarker-guided treatment selection, next-generation sequencing, liquid biopsy,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek